Done Deal: LEO Pharma Finalizes Acquisition of Key Assets From Timber Pharmaceuticals
The Dermatology Digest
JANUARY 23, 2024
LEO Pharma now owns TMB-001 as well as certain other assets from Timber Pharmaceuticals following its chapter 11 bankruptcy filing. All employees of Timber Pharmaceuticals will transition to LEO Pharma’s offices in New Jersey, US, the Company reports. The TMB-001 project continues as planned and without changes within LEO Pharma.
Let's personalize your content